Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 165

1.

Natural Product Mediated Regulation of Death Receptors and Intracellular Machinery: Fresh from the Pipeline about TRAIL-Mediated Signaling and Natural TRAIL Sensitizers.

Shahwar D, Iqbal MJ, Nisa MU, Todorovska M, Attar R, Sabitaliyevich UY, Farooqi AA, Ahmad A, Xu B.

Int J Mol Sci. 2019 Apr 24;20(8). pii: E2010. doi: 10.3390/ijms20082010. Review.

2.

Impact of sex differences and gender specificity on behavioral characteristics and pathophysiology of neurodegenerative disorders.

Ullah MF, Ahmad A, Bhat SH, Abu-Duhier FM, Barreto GE, Ashraf GM.

Neurosci Biobehav Rev. 2019 Jul;102:95-105. doi: 10.1016/j.neubiorev.2019.04.003. Epub 2019 Apr 5. Review.

PMID:
30959072
3.

Anticancer properties of a new non-oxido vanadium(IV) complex with a catechol-modified 3,3'-diindolylmethane ligand.

Dankhoff K, Ahmad A, Weber B, Biersack B, Schobert R.

J Inorg Biochem. 2019 May;194:1-6. doi: 10.1016/j.jinorgbio.2019.02.005. Epub 2019 Feb 13.

PMID:
30784705
4.

Differential Methylation and Acetylation as the Epigenetic Basis of Resveratrol's Anticancer Activity.

Farhan M, Ullah MF, Faisal M, Farooqi AA, Sabitaliyevich UY, Biersack B, Ahmad A.

Medicines (Basel). 2019 Feb 13;6(1). pii: E24. doi: 10.3390/medicines6010024. Review.

5.

Garcinol Sensitizes NSCLC Cells to Standard Therapies by Regulating EMT-Modulating miRNAs.

Farhan M, Malik A, Ullah MF, Afaq S, Faisal M, Farooqi AA, Biersack B, Schobert R, Ahmad A.

Int J Mol Sci. 2019 Feb 13;20(4). pii: E800. doi: 10.3390/ijms20040800.

6.

MicroRNA regulation of TRAIL mediated signaling in different cancers: Control of micro steering wheels during the journey from bench-top to the bedside.

Fayyaz S, Javed Z, Attar R, Farooqi AA, Yaylim I, Ahmad A.

Semin Cancer Biol. 2019 Feb 1. pii: S1044-579X(18)30191-3. doi: 10.1016/j.semcancer.2019.01.007. [Epub ahead of print] Review.

PMID:
30716480
7.

Pentafluorophenyl Substitution of Natural Di(indol-3-yl)methane Strongly Enhances Growth Inhibition and Apoptosis Induction in Various Cancer Cell Lines.

Ahmad A, Dandawate P, Schruefer S, Padhye S, Sarkar FH, Schobert R, Biersack B.

Chem Biodivers. 2019 Apr;16(4):e1900028. doi: 10.1002/cbdv.201900028. Epub 2019 Mar 19.

PMID:
30715794
8.

Gaze through the clinical lens: molecular and clinical advancements of botanicals.

Farooqi AA, Ahmad A.

Future Med Chem. 2019 Jan;11(2):75-77. doi: 10.4155/fmc-2018-0371. Epub 2019 Jan 16. No abstract available.

9.

Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells".

Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH.

Cancer Lett. 2018 Jun 1;423:153. doi: 10.1016/j.canlet.2018.03.020.

10.

Editorial: Cancer Epigenetics.

Ahmad A.

Curr Cancer Drug Targets. 2018;18(1):3-4. doi: 10.2174/156800961801171208144307. No abstract available.

PMID:
29517470
11.

Regulation of Cell Signaling Pathways and miRNAs by Resveratrol in Different Cancers.

Farooqi AA, Khalid S, Ahmad A.

Int J Mol Sci. 2018 Feb 26;19(3). pii: E652. doi: 10.3390/ijms19030652. Review.

12.

Retraction notice to "Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells" [Cancer Lett. 319(2) (2012) 173-181].

Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH.

Cancer Lett. 2018 Feb 1;414:313. doi: 10.1016/j.canlet.2017.11.030. No abstract available.

13.

Prostate cancer: updates on current strategies for screening, diagnosis and clinical implications of treatment modalities.

Tian JY, Guo FJ, Zheng GY, Ahmad A.

Carcinogenesis. 2018 Mar 8;39(3):307-317. doi: 10.1093/carcin/bgx141. Review.

PMID:
29216344
14.

ETV4 Facilitates Cell-Cycle Progression in Pancreatic Cells through Transcriptional Regulation of Cyclin D1.

Tyagi N, Deshmukh SK, Srivastava SK, Azim S, Ahmad A, Al-Ghadhban A, Singh AP, Carter JE, Wang B, Singh S.

Mol Cancer Res. 2018 Feb;16(2):187-196. doi: 10.1158/1541-7786.MCR-17-0219. Epub 2017 Nov 8.

15.

MicroRNA-34a: A Versatile Regulator of Myriads of Targets in Different Cancers.

Farooqi AA, Tabassum S, Ahmad A.

Int J Mol Sci. 2017 Oct 2;18(10). pii: E2089. doi: 10.3390/ijms18102089. Review.

16.

HIV Infection and Bone Abnormalities.

Ahmad AN, Ahmad SN, Ahmad N.

Open Orthop J. 2017 Aug 21;11:777-784. doi: 10.2174/1874325001711010777. eCollection 2017.

17.

Racial health disparities in ovarian cancer: not just black and white.

Srivastava SK, Ahmad A, Miree O, Patel GK, Singh S, Rocconi RP, Singh AP.

J Ovarian Res. 2017 Sep 21;10(1):58. doi: 10.1186/s13048-017-0355-y. Review.

18.

Flavonoids-induced redox cycling of copper ions leads to generation of reactive oxygen species: A potential role in cancer chemoprevention.

Arif H, Sohail A, Farhan M, Rehman AA, Ahmad A, Hadi SM.

Int J Biol Macromol. 2018 Jan;106:569-578. doi: 10.1016/j.ijbiomac.2017.08.049. Epub 2017 Aug 20.

PMID:
28834706
19.

Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells.

Zubair H, Bhardwaj A, Ahmad A, Srivastava SK, Khan MA, Patel GK, Singh S, Singh AP.

Nutr Cancer. 2017 Aug-Sep;69(6):932-942. doi: 10.1080/01635581.2017.1339818. Epub 2017 Jul 18.

20.

Limitations of routine skeletal survey: detection of critical but asymptomatic cervical spine lesion in multiple myeloma.

Batool SS, Iftikhar A, Ahmad AN, Anwer F.

BMJ Case Rep. 2017 Jul 4;2017. pii: bcr-2017-221231. doi: 10.1136/bcr-2017-221231. No abstract available.

Supplemental Content

Loading ...
Support Center